Branden Stansley
About Branden Stansley
Branden Stansley is a Postdoctoral Fellow at Vanderbilt University, specializing in neuropharmacology and the development of novel drug compounds for brain disorders.
Current Role at Vanderbilt University
Branden Stansley currently serves as a Postdoctoral Fellow at Vanderbilt University in Nashville, Tennessee. Since May 2015, he has been contributing to research aimed at understanding brain function in both normal and pathological conditions. His work focuses on neuropharmacology and the development of novel drug compounds to treat serious brain disorders such as Parkinson's, schizophrenia, autism, and PTSD.
Previous Role at The University of Toledo
Before joining Vanderbilt University, Branden Stansley was a PhD Candidate in Neurosciences at The University of Toledo in Toledo, Ohio. From 2010 to 2015, he engaged in research and academia, focusing on his doctoral studies. His tenure at The University of Toledo helped lay the foundation for his specialized work in neuropharmacology.
Educational Background in Neurosciences
Branden Stansley completed his Doctor of Philosophy in Neurosciences at The University of Toledo. He studied there from 2010 to 2015, culminating in a deep understanding of neurological conditions and the development of potential treatments. His dissertation work contributed to his expertise in neuropharmacology and paved the way for future research endeavors.
Undergraduate Education in Psychology
Branden Stansley earned his Bachelor of Arts in Psychology from Queens University of Charlotte. He studied from 2006 to 2010 and developed a foundational understanding of psychological principles. This undergraduate education played a crucial role in his decision to pursue advanced studies in neuroscience.
Research Focus and Contributions
Branden Stansley's research focuses on neuropharmacology with the aim of developing novel drug compounds to treat disorders such as Parkinson's, schizophrenia, autism, and PTSD. His work involves understanding brain function in both normal and pathological states to create therapeutics for these serious brain disorders. His contributions are crucial in advancing medical science and potentially improving the quality of life for individuals affected by these conditions.